Clinical Trials
Psychedelic-Assisted Clinical Trials at Pacific Neuroscience Institute
Our clinical trials work at TRIP is aiming to help develop novel psychedelic therapies and advance psychedelic medicines including psilocybin, LSD derivatives, 5-MeO-DMT and MDMA towards FDA approval.
We will continue conducting clinical trials for conditions such as depression, anxiety, addiction and grief. In the future, we plan to expand our focus to trials in patients with brain injury and neurodegenerative conditions such as traumatic brain injury (TBI), stroke, mild cognitive impairment, dementia, and pain syndromes. It is in these areas where the neuroplasticity-promoting effects of psychedelics may be “game-changers” in helping to restore cognitive function, halt further deterioration and ultimately improve quality of life.
Clinic: 1301 20th St #540, Santa Monica, CA 90404 | 310-582-7611
Open Trials
Completed Trials
Generalized Anxiety Disorder
A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms:
Multi-site trial. Completed enrollment of 15 patients. Sponsor: MindMed
Start Up Phase Trials
Brain Tumor Distress
Pilot trial of psilocybin-assisted therapy for psychiatric distress in patients with brain tumors (Investigator-Initiated Trial):
To assess feasibility and safety of psilocybin-assisted therapy in patients with brain tumors. Enrollment Winter 2023
Videos about Psychedelic-Assisted Therapy
Meet Dr. Heinzerling
Dr. Heinzerling is the Director, Pacific Treatment & Research In Psychedelics Program; Internal Medicine – Addiction Medicine, Brain Health Center. He practices internal medicine and is an addiction medicine specialist…
Psychedelic-Assisted Therapy at Pacific Neuroscience Institute
Dr. Keith Heinzerling is an addiction medicine specialist and Director of Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute in Santa Monica, CA. Learn about how psychedelic-assisted therapy…
Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT
39. A Life-Changing Clinical Trial with Psychedelics | Vikki’s Grateful Patient Story
Vikki was walking her dog and listening to NPR in Santa Monica one day, when she heard an advertisement for an unusual medical trial. Pacific Neuroscience Institute was studying whether…
Think Neuro Podcast: The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg
Addiction and depression are two of the most widespread conditions in all of medicine. After decades of research, doctors are still looking for alternatives for when medication and cognitive training…
Healing with Visual Art, Music & Mushrooms with Louie Schwartzberg (ft. Deepak Chopra & Dr. Dan Kelly)
https://fungiglobalsummit.com/ Voices from the Underground is The Deep Dive, Intimate Conversations with Thought Leaders & Fungi Experts hosted by Louie Schwartzberg. Get Premium Access and join Louie as he digs…
Brain Injuries and Psychedelics
Ian McCall is a former professional MMA fighter who suffered from symptoms of traumatic brain injuries. After retirement, McCall experienced confusion, anger issues, depression, and suicidal ideation. Feeling hopeless, he…
Psychedelics Renaissance | Dr. Daniel Kelly
Dr. Dan Kelly is the director and one of the four co founders of the Pacific Neuroscience Institute, a multispecialty group of over 35 physicians working across nine centers of…
Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute | Explainer
At PNI’s Treatment & Research In Psychedelics (TRIP) Program, we conduct clinical trails at the forefront of innovative and transformative medicine. TRIP, spearheaded by Daniel Kelly, MD and Keith Heinzerling,…
NBC News Features Treatment & Research In Psychedelics (TRIP) at PNI
NBC News features Pacific Neuroscience Institute’s Dr. Daniel Kelly & Dr. Keith Heinzerling, and filmmaker Louie Schwartzberg, and PNI’s groundbreaking psychedelic-assisted clinical trial for alcohol use disorder which launched in…
Psychedelic-Assisted Therapy: A New Dawn for Mental Health | Daniel Kelly, MD
Adapted from lecture at Claremont McKenna College Thu, September 16, 2021 Alum, Daniel Kelly, M.D. ’82, a neurosurgeon and neuroscientist, discusses the history, current state and future opportunities of psychedelic-assisted…
Meet Dr. Heinzerling
Psychedelic-Assisted Therapy at Pacific Neuroscience Institute
Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT
39. A Life-Changing Clinical Trial with Psychedelics | Vikki’s Grateful Patient Story
The Promise of Psychedelics | Dr. Keith Heinzerling & Louie Schwartzberg
Healing with Visual Art, Music & Mushrooms with Louie Schwartzberg (ft. Deepak Chopra & Dr. Dan Kelly) | Fungi Global Summit
Brain Injuries and Psychedelics
Psychedelics Renaissance | Dr. Daniel Kelly
Treatment & Research In Psychedelics (TRIP) at Pacific Neuroscience Institute | Explainer
NBC News Features Treatment & Research In Psychedelics (TRIP) Program at PNI
Psychedelic-Assisted Therapy: A New Dawn for Mental Health | Daniel Kelly, MD
Articles about psychedelic-assisted therapy
If you or someone you know is in crisis, call the National Suicide Prevention Lifeline (Lifeline) at 1-800-273-TALK (8255), or text the Crisis Text Line (text HELLO to 741741). Both services are free and available 24 hours a day, seven days a week. The deaf and hard of hearing can contact the Lifeline via TTY at 1-800-799-4889. All calls are confidential. Contact social media outlets directly if you are concerned about a friend’s social media updates or dial 911 in an emergency. Learn more on the Lifeline’s website or the Crisis Text Line’s website.
For more information about treatment and research studies at the TRIP program please contact Dr. Heinzerling.
Virtual Video Visits Are Available
Our specialists have consultation openings for new patients anywhere in California.
Treatment with Ketamine: 310-582-7612
Clinical Trials: 310-582-7611